MCAP MedCap AB (publ)

54.19USD550.50 SEK · STO+0.64%Mkt Cap: 811.46M USDP/E: 30.08

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It pref…

Key Statistics

Company
Market Cap811.46M USD
Enterprise Value827.87M USD
Revenue (TTM)233.69M USD
Gross Profit121.67M USD
Net Income (TTM)21.63M USD
Revenue/Share15.60 USD
Last Price54.19 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees663
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0009160872
Valuation
P/E (Trailing)30.08
P/E (Forward)108.58
PEG—
EV/EBITDA16.52
EV/Revenue3.54
P/S3.47
P/B4.83
EPS (TTM)1.80 USD
EPS (Forward)0.50 USD
52W Range
43.3167% of range59.50
52W High59.50 USD
52W Low43.31 USD
Profitability
Gross Margin58.64%
Oper. Margin16.30%
EBITDA Margin21.45%
Profit Margin10.43%
ROE15.14%
ROA8.43%
ROIC14.04%
ROCE13.68%
Growth
Revenue Growth20.40%
Earnings Growth66.50%
Cash Flow & Leverage
Operating CF33.73M USD
CapEx (TTM)6.12M USD
FCF Margin16.17%
FCF Yield4.66%
Net Debt16.23M USD
Net Debt/EBITDA0.32
Net Debt/FCF0.43
Balance Sheet
Debt/Equity0.33
Current Ratio1.71
Quick Ratio1.17
Book Value/Sh11.22 USD
Cash/Share1.79 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 27, 2016
Analyst Consensus
Rating—
Target (Mean)63.73 USD
Upside (mean)+17.6%
Target Range59.06 USD – 68.41 USD
59.06+17.6% to mean68.41
# Analysts2
Ownership
Shares Out.14.98M
Float14.85M
Insiders20.91%
Institutions55.62%
Technical
SMA 5052.94 (+2.4%)
SMA 20050.94 (+6.4%)
Beta0.42
S&P 52W Chg12.00%
Avg Vol (30d)21.75K
Avg Vol (10d)17.73K
Technical Indicators
RSI (14)51.3
MACD2.8518
MACD Signal4.3418
MACD Hist.-1.4900
BB Upper57.15 USD
BB Middle54.60 USD
BB Lower52.06 USD
BB Width9.33%
ATR (14)1.454 USD
Vol Ratio (20d)0.32x

About MedCap (STO: MCAP)

›

MedCap (STO: MCAP) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 663 employees.

The shares were at 550.50 SEK on 19 November 2026, down 0.6% over 52 weeks. Its 52-week range is 440.00 SEK to 604.50 SEK: the price is 8.9% below the high and 25.1% above the low.

At a market capitalisation of 8.24B SEK, it trades at 30.1 times trailing earnings and 108.6 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 17% for MCAP.

MedCap reports return on equity of 15.1%, an operating margin of 16.3% and revenue up 20.4% year over year.

Its debt exceeds its cash by 164.90M SEK, a debt-to-equity ratio of 0.33. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 647.50 SEK is 17.6% above the current price. The next earnings report is expected on 5 February 2027.